CorTechs has received SBIR funding from the US National Institute of Aging to use data collected from the NIH and pharmaceutical-industry co-sponsored Alzheimer's Disease Neuroimaging Initiative (ADNI) project, to establish an indication for use for NeuroQuant® as an adjunctive tool in the assessment of patients with AD.
Cortechs Labs - About CorTechs Labs : Company Overview: "CorTechs Labs Inc is a group of scientists, engineers, business professionals, and clinical specialists dedicated to bringing cutting edge brain image analysis technologies to the commercial market.
CorTechs was incorporated in 2001 by leaders in neuroimaging research in order to create advanced medical image analysis solutions for quantitative analysis of the structure and function of the human brain. An extensive and growing body of scientific and clinical research indicates that such tools may help physicians to more effectively diagnose and treat serious neurological disorders that affect millions of patients worldwide. It is our mission to effectively translate the fruits of such research into routine clinical practice.
Many empirical studies have shown that neurodegenerative disorders produce changes in the brain that can be measured with MRI scanning. Accurately characterizing the extent and progression of cortical atrophy from MRIs can only be accomplished only by comparing numerical information with normative data. Existing semi-manual methods for deriving numerical information from MRI scans are too slow and expensive for use outside of small research studies, and lack the reliability necessary for routine clinical application. CorTechs' quantitative image analysis technologies offer a solution to this problem."